Literature DB >> 2019289

Major histocompatibility complex class II hyperexpression on B cells in interleukin 4-transgenic mice does not lead to B cell proliferation and hypergammaglobulinemia.

W Müller1, R Kühn, K Rajewsky.   

Abstract

The murine interleukin 4 (IL4)-encoding cDNA expressed under the control of the immunoglobulin heavy chain enhancer/promoter was inserted into the mouse germ line. All B cells present in the IL4 transgenic mice show a marked increase in expression of class II histocompatibility (Ia) antigens compared to B cells from control mice. In vivo 5-bromo-2'-deoxyuridine incorporation and cell cycle analysis revealed no significant increase in B cell proliferation in spleens of IL4 transgenic mice compared to littermate controls. Likewise, serum immunoglobulin concentrations in IL4 transgenic mice were not increased. From these experiments we conclude that Ia hyperexpression on B cells per se does not induce activation of autoreactive T cells leading to B cell proliferation or hypergammaglobulinemia.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2019289     DOI: 10.1002/eji.1830210410

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  11 in total

Review 1.  Transgenic mice in the study of cytokine function.

Authors:  J Taverne
Journal:  Int J Exp Pathol       Date:  1993-12       Impact factor: 1.925

2.  Abnormal heart rate and body temperature in mice lacking thyroid hormone receptor alpha 1.

Authors:  L Wikström; C Johansson; C Saltó; C Barlow; A Campos Barros; F Baas; D Forrest; P Thorén; B Vennström
Journal:  EMBO J       Date:  1998-01-15       Impact factor: 11.598

3.  Phenotypic and physiologic characterization of transgenic mice expressing interleukin 4 in the lung: lymphocytic and eosinophilic inflammation without airway hyperreactivity.

Authors:  J A Rankin; D E Picarella; G P Geba; U A Temann; B Prasad; B DiCosmo; A Tarallo; B Stripp; J Whitsett; R A Flavell
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-23       Impact factor: 11.205

4.  Progression of renal disease in interleukin-4 transgenic mice: involvement of transforming growth factor-beta.

Authors:  B M Rüger; Q Hasan; K J Erb; P F Davis
Journal:  Int J Exp Pathol       Date:  1999-06       Impact factor: 1.925

5.  Constitutive expression of interleukin (IL)-4 in vivo causes autoimmune-type disorders in mice.

Authors:  K J Erb; B Rüger; M von Brevern; B Ryffel; A Schimpl; K Rivett
Journal:  J Exp Med       Date:  1997-01-20       Impact factor: 14.307

Review 6.  Analysis of the immune system with transgenic mice: B cell development and lymphokines.

Authors:  A Iglesias
Journal:  Experientia       Date:  1991-09-15

Review 7.  Therapeutic strategies for SLE involving cytokines: mechanism-oriented therapies especially IFN-gamma targeting gene therapy.

Authors:  Toshiharu Hayashi
Journal:  J Biomed Biotechnol       Date:  2010-08-17

8.  Interleukin-4 protects against a genetically linked lupus-like autoimmune syndrome.

Authors:  M L Santiago; L Fossati; C Jacquet; W Müller; S Izui; L Reininger
Journal:  J Exp Med       Date:  1997-01-06       Impact factor: 14.307

9.  Behavior of visceral Leishmania donovani in an experimentally induced T helper cell 2 (Th2)-associated response model.

Authors:  H W Murray; J Hariprashad; R L Coffman
Journal:  J Exp Med       Date:  1997-03-03       Impact factor: 14.307

10.  Developmental and functional impairment of T cells in mice lacking CD3 zeta chains.

Authors:  H Ohno; T Aoe; S Taki; D Kitamura; Y Ishida; K Rajewsky; T Saito
Journal:  EMBO J       Date:  1993-11       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.